These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines. Asou H, Koike M, Elstner E, Cambell M, Le J, Uskokovic MR, Kamada N, Koeffler HP. Blood; 1998 Oct 01; 92(7):2441-9. PubMed ID: 9746784 [Abstract] [Full Text] [Related]
3. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP. Anticancer Res; 1999 Oct 01; 19(3A):1689-97. PubMed ID: 10470102 [Abstract] [Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1). Muto A, Kizaki M, Yamato K, Kawai Y, Kamata-Matsushita M, Ueno H, Ohguchi M, Nishihara T, Koeffler HP, Ikeda Y. Blood; 1999 Apr 01; 93(7):2225-33. PubMed ID: 10090931 [Abstract] [Full Text] [Related]
5. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation. Shiohara M, Uskokovic M, Hisatake J, Hisatake Y, Koike K, Komiyama A, Koeffler HP. Cancer Res; 2001 Apr 15; 61(8):3361-8. PubMed ID: 11309293 [Abstract] [Full Text] [Related]
6. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest. Ikezoe T, Chen SS, Heber D, Taguchi H, Koeffler HP. Prostate; 2001 Dec 01; 49(4):285-92. PubMed ID: 11746275 [Abstract] [Full Text] [Related]
7. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP. Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668 [Abstract] [Full Text] [Related]
8. Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. Campbell MJ, Elstner E, Holden S, Uskokovic M, Koeffler HP. J Mol Endocrinol; 1997 Aug 01; 19(1):15-27. PubMed ID: 9278857 [Abstract] [Full Text] [Related]
9. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP. Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928 [Abstract] [Full Text] [Related]
10. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Steiner M, Priel I, Giat J, Levy J, Sharoni Y, Danilenko M. Nutr Cancer; 2001 Aug 01; 41(1-2):135-44. PubMed ID: 12094616 [Abstract] [Full Text] [Related]
11. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. Campbell MJ, Reddy GS, Koeffler HP. J Cell Biochem; 1997 Sep 01; 66(3):413-25. PubMed ID: 9257197 [Abstract] [Full Text] [Related]
12. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells. Funato K, Miyazawa K, Yaguchi M, Gotoh A, Ohyashiki K. Leukemia; 2002 Aug 01; 16(8):1519-27. PubMed ID: 12145693 [Abstract] [Full Text] [Related]
14. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP. Cancer Res; 1999 Aug 15; 59(16):4023-9. PubMed ID: 10463602 [Abstract] [Full Text] [Related]
15. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation. Ohnishi K, Tobita T, Sinjo K, Takeshita A, Ohno R. Leuk Lymphoma; 1998 Nov 15; 31(5-6):599-608. PubMed ID: 9922051 [Abstract] [Full Text] [Related]
16. The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells. James SY, Williams MA, Kelsey SM, Newland AC, Colston KW. Biochem Pharmacol; 1997 Sep 01; 54(5):625-34. PubMed ID: 9337080 [Abstract] [Full Text] [Related]
17. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Shiohara M, Dawson MI, Hobbs PD, Sawai N, Higuchi T, Koike K, Komiyama A, Koeffler HP. Blood; 1999 Mar 15; 93(6):2057-66. PubMed ID: 10068679 [Abstract] [Full Text] [Related]
18. Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells. Shen JC, Klein RD, Wei Q, Guan Y, Contois JH, Wang TT, Chang S, Hursting SD. Mol Carcinog; 2000 Oct 15; 29(2):92-102. PubMed ID: 11074606 [Abstract] [Full Text] [Related]
19. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway. O'Kelly J, Uskokovic M, Lemp N, Vadgama J, Koeffler HP. J Steroid Biochem Mol Biol; 2006 Aug 15; 100(4-5):107-16. PubMed ID: 16777406 [Abstract] [Full Text] [Related]
20. Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Elstner E, Campbell MJ, Munker R, Shintaku P, Binderup L, Heber D, Said J, Koeffler HP. Prostate; 1999 Aug 01; 40(3):141-9. PubMed ID: 10398275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]